Alessio Ciulli: At the Forefront of Targeted Protein Degradation

episode

Back of the Napkin - Inspiring Stories from Biotech Pioneers not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Updates on the Ireland and Israel match 15 min · 27 Sep 2026 · The Pat Kenny Show

NPR News: 09-27-2026 9AM EDT 5 min · 27 Sep 2026 · NPR News Now

9AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

Not ALL Good People go to Heaven 58 min · 27 Sep 2026 · Camp Gagnon

CIA Spy: The Deep State Is Real — And You’re Already Under Their Control 12 min · 27 Sep 2026 · EverydaySpy Podcast

UPDATE: Police Say Black Woman’s Hanging Was “Staged”, After 3rd (Black) Man Arrested For Her Murder 33 min · 27 Sep 2026 · Amy Robach & T.J. Holmes Present

Report any issue

Source

Recorded30 Jun 2023

Publisherfeeds.zencastr.com ↗

Handlerec:4638146

Show notes

Alessio Ciulli is a Professor and Chair of Chemical Structural Biology at the University of Dundee, where he is also the founder and director of the Centre for Targeted Protein Degradation (CeTPD). He is also the scientific founder of Amphista Therapeutics. This conversation covers the significant moments in Alessio’s career where he began to shape an exciting new approach in drug discovery: targeted protein degradation.CeTPD page: https://www.dundee.ac.uk/cetpdAlessio’s group page: https://www.dundee.ac.uk/people/alessio-ciulliAlessio’s Twitter: https://twitter.com/alessiociulli

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in